CDMO News
AmbioPharm Expands Shanghai Facility with $28 Million Investment
AmbioPharm, a U.S.-based pharmaceutical services company, has announced the groundbreaking of a $28 million expansion at its Shanghai site. The project, set to add 70,000 square feet of manufacturing capacity, is designed to meet growing global demand for peptide therapeutics.
16 January 2025
